Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
19 Jan 2024
Historique:
received: 20 05 2023
revised: 27 08 2023
accepted: 15 01 2024
medline: 3 2 2024
pubmed: 3 2 2024
entrez: 2 2 2024
Statut: aheadofprint

Résumé

Intraductal papillary neoplasm of the bile ducts (IPNB) is a rare disease in Western countries. The aim of this study was to compare tumor characteristics, management strategies, and outcomes between Western and Eastern patients who underwent surgical resection for IPNB. A multi-institutional retrospective series of patients with IPNB undergoing surgery between January 2010 and December 2020 was gathered under the auspices of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), and at Nagoya University Hospital, Japan. A total of 85 patients (51% male; median age 66 years) from 28 E-AHPBA centers were compared to 91 patients (64% male; median age 71 years) from Nagoya. Patients in Europe had more multiple lesions (23% vs 2%, P < .001), less invasive carcinoma (42% vs 85%, P < .001), and more intrahepatic tumors (52% vs 24%, P < .001) than in Nagoya. Patients in Europe experienced less 90-day grade >3 Clavien-Dindo complications (33% vs 68%, P < .001), but higher 90-day mortality rate (7.0% vs 0%, P = .03). R0 resections (81% vs 82%) were similar. Overall survival, excluding 90-day postoperative deaths, was similar in both regions. Despite performing more extensive resections, the low perioperative mortality rate observed in Nagoya was probably influenced by a combination of patient-, tumor-, and surgery-related factors.

Sections du résumé

BACKGROUND BACKGROUND
Intraductal papillary neoplasm of the bile ducts (IPNB) is a rare disease in Western countries. The aim of this study was to compare tumor characteristics, management strategies, and outcomes between Western and Eastern patients who underwent surgical resection for IPNB.
METHODS METHODS
A multi-institutional retrospective series of patients with IPNB undergoing surgery between January 2010 and December 2020 was gathered under the auspices of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), and at Nagoya University Hospital, Japan.
RESULTS RESULTS
A total of 85 patients (51% male; median age 66 years) from 28 E-AHPBA centers were compared to 91 patients (64% male; median age 71 years) from Nagoya. Patients in Europe had more multiple lesions (23% vs 2%, P < .001), less invasive carcinoma (42% vs 85%, P < .001), and more intrahepatic tumors (52% vs 24%, P < .001) than in Nagoya. Patients in Europe experienced less 90-day grade >3 Clavien-Dindo complications (33% vs 68%, P < .001), but higher 90-day mortality rate (7.0% vs 0%, P = .03). R0 resections (81% vs 82%) were similar. Overall survival, excluding 90-day postoperative deaths, was similar in both regions.
DISCUSSION CONCLUSIONS
Despite performing more extensive resections, the low perioperative mortality rate observed in Nagoya was probably influenced by a combination of patient-, tumor-, and surgery-related factors.

Identifiants

pubmed: 38307773
pii: S1365-182X(24)00009-1
doi: 10.1016/j.hpb.2024.01.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Auteurs

Núria Lluís (N)

Division of Hepatobiliary and Pancreas Surgery, Miami Cancer Institute, Miami, FL, USA. Electronic address: nurialluisv@gmail.com.

Shunsuke Onoe (S)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Mario Serradilla-Martín (M)

Instituto de Investigación Sanitaria Aragón, Department of Surgery, Miguel Servet University Hospital, Zaragoza, Spain. Electronic address: marioserradilla@hotmail.com.

Mar Achalandabaso (M)

HPB Surgery and Transplantation, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Takashi Mizuno (T)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

François Jehaes (F)

HPB Surgery & Liver Transplantation, Beaujon Hospital, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Clichy, France.

Bobby V M Dasari (BVM)

Liver Transplant and HPB Surgery, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Sara Mambrilla-Herrero (S)

Hepatobiliary Surgery and Liver Transplant Unit, Cruces University Hospital, Bilbao, Spain.

Ernesto Sparrelid (E)

Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Anita Balakrishnan (A)

Cambridge HPB Unit, Cambridge University Hospitals NHS Foundation Trust, and Department of Surgery, University of Cambridge, Cambridge, UK.

Frederik J H Hoogwater (FJH)

HPB Surgery and Liver Transplantation, and Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

María J Amaral (MJ)

General Surgery, Centro Hospitalar e Universitário de Coimbra, and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Bodil Andersson (B)

Department of Clinical Science Lund, Surgery, Lund University and Skane University Hospital, Lund, Sweden.

Frederik Berrevoet (F)

General and HPB Surgery, and Liver Transplantation, University Hospital Gent, Gent, Belgium.

Alexandre Doussot (A)

Department of Digestive Surgical Oncology, Liver Transplantation Unit, CHU Besançon, France.

Víctor López-López (V)

General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain.

Olivier Detry (O)

Abdominal Surgery and Transplantation, CHU Liege, University of Liege, Belgium.

Carlos Domingo-Del Pozo (CD)

General and Digestive Surgery, Hospital Doctor Peset, Valencia, Spain.

Nikolaos Machairas (N)

Second Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Athens, Greece.

Damján Pekli (D)

Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.

Cándido F Alcázar-López (CF)

HPB Surgery and Liver Transplantation, Dr. Balmis General University Hospital, and Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.

Horacio Asbun (H)

Division of Hepatobiliary and Pancreas Surgery, Miami Cancer Institute, Miami, FL, USA.

Bergthor Björnsson (B)

Department of Surgery in Linköping and Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Thalis Christophides (T)

General Surgery Department, HPB Division, Nicosia General Hospital, Nicosia, Cyprus.

Alberto Díez-Caballero (A)

Quirúrgica Cirujanos Asociados, Centro Médico Teknon, Barcelona, Spain.

David Francart (D)

Department of Abdominal Surgery, CHC Groupe Santé, Liège, Belgium.

Colin B Noel (CB)

HPB Clinical Unit, Gastrointestinal Surgery, Universitas Academic Hospital, University of the Free State, South Africa.

Donzília Sousa-Silva (D)

HEBIPA Surgery, Centro Hospitalar Universitário do Porto, Portugal.

Enrique Toledo-Martínez (E)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

George N Tzimas (GN)

HPB Surgery, Department of Surgery, Hygeia Hospital, Athens, Greece.

Sheraz Yaqub (S)

HPB Surgery, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Junpei Yamaguchi (J)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Safi Dokmak (S)

HPB Surgery & Liver Transplantation, Beaujon Hospital, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Clichy, France.

Mikel Prieto-Calvo (M)

Hepatobiliary Surgery and Liver Transplant Unit, Cruces University Hospital, Bilbao, Spain.

Melroy A D'Souza (MA)

Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Harry V M Spiers (HVM)

Cambridge HPB Unit, Cambridge University Hospitals NHS Foundation Trust, and Department of Surgery, University of Cambridge, Cambridge, UK.

Marius C van den Heuvel (MC)

HPB Surgery and Liver Transplantation, and Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Ramón Charco (R)

HPB Surgery and Transplantation, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Mickaël Lesurtel (M)

HPB Surgery & Liver Transplantation, Beaujon Hospital, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Clichy, France.

Tomoki Ebata (T)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

José M Ramia (JM)

HPB Surgery and Liver Transplantation, Dr. Balmis General University Hospital, and Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Miguel Hernández University, Alicante, Spain.

Classifications MeSH